October 28, 2016
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Attention: Suzanne Hayes, Assistant Director, Office of Healthcare and Insurance
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
| Re: | Xenetic Biosciences, Inc. Registration Statement on Form S-1 (File No. 333-211249) |
Ladies and Gentlemen:
We hereby request withdrawal of our previous request for acceleration of the above-referenced Registration Statement, which was dated October 26, 2016.
Thank you for your assistance in this matter.
Very truly yours,
Xenetic Biosciences, Inc.
By: /s/ M. Scott Maguire
Michael Scott Maguire
Chief Executive Officer
| cc: | David Strupp | Ladenburg Thalmann & Co. Inc. |
| Michael Maline | Goodwin Procter LLP | |
| Mitchell D. Goldsmith | Taft Stettinius & Hollister | |
| Jeremy Stonehill | Taft Stettinius & Hollister | |